Purpose To compare the efficacy and safety of non-benzodiazepines (non-BZDs) to
benzodiazepines (BZDs) in the treatment of alcohol withdrawal syndrome (AWS). Methods …

Alcohol use disorder (AUD) is a significant contributor to morbidity and mortality in the
United States. It contributes to over 140,000 annual deaths, to over 200 related diseases …

Baclofen is the only drug that has been investigated in randomized controlled studies for anti-
craving in patients with alcohol use disorder (AUD) and liver disease. However, the results …

The global increase in pharmaceutical consumption, driven by factors such as aging
populations and chronic diseases, has raised concerns regarding the environmental impact …

Background Prior research suggests a potential relationship between the nonmedical use of
gabapentin and use of opioid agonist medications (OAMs), buprenorphine and methadone …

Inflammatory arthritis leads to peripheral nerve sensitization, but the therapeutic effect is
often unsatisfactory. Our preliminary studies have found that in mice with inflammatory …

In our study, the antioxidant and anti-inflammatory effects of different lichen applications
were investigated in rats using an experimental ethanol toxicity model. 48 rats were used in …

Alcohol-associated liver disease is a common and severe sequela of excessive alcohol use;
effective treatment requires attention to both liver disease and underlying alcohol use …

Alcohol is a commonly used psychoactive agent, with up to 40% of people reporting heavy
alcohol use or alcohol use disorder during their lifetime. 1, 2, 3 Alcohol use disorder is …

Repurposing drugs for the treatment of alcohol dependence involves the use of drugs that
were initially developed for other conditions, but have shown promise in reducing alcohol …